SCHEMBL21027974

SCHEMBL21027974

O=C(OCc1ccccc1)c1ccc2c(c1)Cc1ccccc1N2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 5/20 0.51
LMNA P02545 4/20 0.51
KMT2A Q03164 4/20 0.51
SLC6A2 P23975 1/20 0.51
SLC6A3 Q01959 1/20 0.51
RAB9A P51151 5/20 0.49
ALDH1A1 P00352 5/20 0.49
MAPT P10636 3/20 0.49
NPC1 O15118 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
HPGD P15428 1/20 0.46
SRD5A1 P18405 1/20 0.44
SRD5A2 P31213 1/20 0.44
KDM4E B2RXH2 1/20 0.43
GAA P10253 1/20 0.42
HTT P42858 1/20 0.42
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1115098 0.81 MAPT (0.63) TDP1LMNAKMT2ASLC6A2SLC6A3
SCHEMBL30935799 0.81 MAPT (0.63) TDP1LMNAKMT2ASLC6A2SLC6A3
SCHEMBL27512078 0.80 MAPT (0.48) TDP1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL20074352 0.78 KMT2A (0.53) TDP1LMNAKMT2ASLC6A2SLC6A3
SCHEMBL21027971 0.77 BRD4 (0.56) TDP1LMNAKMT2ASLC6A2SLC6A3
SCHEMBL21027973 0.77 ALDH1A1 (0.51) TDP1LMNAKMT2ASLC6A2SLC6A3
SCHEMBL16585812 0.76 MAPT (0.60) TDP1LMNAKMT2ASLC6A2SLC6A3
SCHEMBL27605930 0.76 TDP1 (0.50) TDP1LMNAKMT2ASLC6A2SLC6A3
SCHEMBL30955004 0.76 MAPT (0.60) TDP1LMNAKMT2ASLC6A2SLC6A3
SCHEMBL22801020 0.76 TDP1 (0.57) TDP1LMNAKMT2ASLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210002230-A1 OXOACRIDINYL ACETIC ACID DERIVATIVES AND METHODS OF USE Stingthera, Inc. 2021-01-07 US disclosed
US-10745358-B2 Oxoacridinyl acetic acid derivatives and methods of use SILICON SWAT, INC. (US) 2020-08-18 US disclosed
US-20190161449-A1 OXOACRIDINYL ACETIC ACID DERIVATIVES AND METHODS OF USE SILICON SWAT, INC. 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190161449-A1 OXOACRIDINYL ACETIC ACID DERIVATIVES AND METHODS OF USE STING1, IRF3, CGAS TDP1 140/4885LMNA 2479/4885KMT2A 4787/4885
US-20210002230-A1 OXOACRIDINYL ACETIC ACID DERIVATIVES AND METHODS OF USE STING1, IRF3, CGAS TDP1 140/4885LMNA 2479/4885KMT2A 4787/4885
US-10745358-B2 Oxoacridinyl acetic acid derivatives and methods of use STING1, IRF3, CGAS TDP1 140/4885LMNA 2479/4885KMT2A 4787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.